Form NT 10-Q Cellular Biomedicine For: Sep 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Cellular Biomedicine Group (CBMG) Swings to Q3 Loss
November 19, 2014 4:54 PM ESTCellular Biomedicine Group (NASDAQ: CBMG) reported Q3 EPS of ($0.31), versus $0.09 reported last year.
For earnings history and earnings-related data on Cellular Biomedicine Group (CBMG) click here.
... More